|
1
|
Randall N, Courville EL, Baughn L, Afrin L, Ustun C. Bosutinib, a Lyn/Btk inhibiting tyrosine kinase inhibitor, is ineffective in advanced systemic mastocytosis. Am J Hematol 2015; 90:E74. [PMID: 25641616 DOI: 10.1002/ajh.23942] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2014] [Accepted: 01/08/2015] [Indexed: 01/26/2023]
Affiliation(s)
- Nicole Randall
- Division of HematologyôOncology and Transplantation; Department of Medicine; University of Minnesota; Minneapolis Minnesota
| | - Elizabeth L. Courville
- Department of Pathology and Laboratory Medicine; University of Minnesota; Minneapolis Minnesota
| | - Linda Baughn
- Department of Pathology and Laboratory Medicine; University of Minnesota; Minneapolis Minnesota
| | - Lawrence Afrin
- Division of HematologyôOncology and Transplantation; Department of Medicine; University of Minnesota; Minneapolis Minnesota
| | - Celalettin Ustun
- Division of HematologyôOncology and Transplantation; Department of Medicine; University of Minnesota; Minneapolis Minnesota
| |
Collapse
|